Menu
Subscribe - Individual
Subscribe - Biotech Premium (Corporate)
Home
About Us
Subscribe
Subscribe Individual
Subscribe Biotech Premium (Corporate)
Premium Biotech Coverage
Current News
Special Features
Company Index
Index Table
Summit
Summit History
20th Bioshares Biotech Summit
Contact
Contact Us
Email Alerts
Categories
Categories
Actinogen (ACW)
Aroa Biosurgery (ARX)
Blinklab (BB1)
Blog
Clever Culture Systems (CC5)
Clinuvel Pharmaceuticals (CUV)
Cogstate (CGS)
Cynata Therapeutics
Dimerix (DXB)
Imugene (IMU)
Neuren Pharmaceuticals (NEU)
Syntara (SNT) (previously Pharmaxis, PXS)
Uncategorized
May 5th, 2026
Dimerix Clears Second Interim Review; Focus on Traditional Approval Route for DMX200
Read More
May 5th, 2026
Syntara: First of Five Milestones Approaching
Read More
May 5th, 2026
Clever Culture Systems - Continues Inroads into Top 20 Pharma
Read More
May 5th, 2026
Neuren Pharmaceuticals Update - Dividends on the Way?
Read More
April 20th, 2026
Another Strong Sales Quarter for Cogstate
Read More
April 20th, 2026
Blinklab Raises $17.5 Million
Read More
March 26th, 2026
Clinuvel CEO to Continue with Key Strategy Role
Read More
March 26th, 2026
Blinklab Technology Selected by Moroccan Government for National Autism Screening Program
Read More
March 12th, 2026
Imugene Announces $20 million Capital Raise
Read More
March 12th, 2026
Dimerix Completes Enrolment in Global Phase III Study & First Treatment of Last Patient
Read More
March 12th, 2026
Clinuvel Competitor Receives FDA Setback
Read More
February 20th, 2026
Clever Culture Systems - Strong 24 Months Ahead
Read More
February 20th, 2026
Aroa Biosurgery Update
Read More
February 20th, 2026
Actinogen Medical 'Increasingly Confident of Positive Outcome'
Read More
February 20th, 2026
Cogstate Half Year Results
Read More
January 30th, 2026
Cogstate - Half Year Update, Record Level of New Sales Opportunities
Read More
January 30th, 2026
Actinogen Medical Gets Green Light from Data Monitoring Committee
Read More
December 23rd, 2025
Cogstate - "Record Level of Opportunities"
Read More
December 23rd, 2025
Bioshares Top 6 Picks for 2026: Clinuvel Pharmaceuticals - First Phase III Trial Readout in Vitiligo
Read More
December 23rd, 2025
Top 6 Pick: Syntara - 5 Clinical Study Readouts in 2026
Read More
Pages
1
2
3
4
5
6
7
8
9
10
11
